[go: up one dir, main page]

MX9304070A - Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol. - Google Patents

Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol.

Info

Publication number
MX9304070A
MX9304070A MX9304070A MX9304070A MX9304070A MX 9304070 A MX9304070 A MX 9304070A MX 9304070 A MX9304070 A MX 9304070A MX 9304070 A MX9304070 A MX 9304070A MX 9304070 A MX9304070 A MX 9304070A
Authority
MX
Mexico
Prior art keywords
inhibitors
piperidyl
piperidylsulfoxamides
piperidylamides
sulphonamides
Prior art date
Application number
MX9304070A
Other languages
English (en)
Inventor
Marion W Wannamaker
William A Vansickle
William R Moore
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of MX9304070A publication Critical patent/MX9304070A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other Liquid Machine Or Engine Such As Wave Power Use (AREA)

Abstract

La presente invención se relaciona con ciertas piperidilamidas, sulfonamidas y sulfoxamidas novedosas, las cuales son útiles como ihibidores de la biosíntesis del colesterol y como agentes los cuales disminuyen el colesterol en suero total en pacientes que necesitan del mismo.
MX9304070A 1992-07-08 1993-07-07 Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol. MX9304070A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91060492A 1992-07-08 1992-07-08

Publications (1)

Publication Number Publication Date
MX9304070A true MX9304070A (es) 1994-02-28

Family

ID=25429048

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304070A MX9304070A (es) 1992-07-08 1993-07-07 Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol.

Country Status (14)

Country Link
US (2) US5350758A (es)
EP (1) EP0650474B1 (es)
JP (1) JPH07508732A (es)
KR (1) KR100286410B1 (es)
AT (1) ATE169618T1 (es)
AU (1) AU678973B2 (es)
CA (1) CA2136841C (es)
DE (1) DE69320352T2 (es)
ES (1) ES2120506T3 (es)
IL (1) IL106237A0 (es)
MX (1) MX9304070A (es)
NZ (1) NZ253592A (es)
WO (1) WO1994001404A1 (es)
ZA (1) ZA934777B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
KR100601501B1 (ko) * 2004-09-24 2006-07-18 삼성에스디아이 주식회사 이차전지의 팩 케이스
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
JP2013528172A (ja) 2010-05-21 2013-07-08 ファイザー・インク ２−フェニルベンゾイルアミド
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MA54261B1 (fr) 2019-01-18 2025-03-28 Astrazeneca Ab Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2580411A (en) * 1948-10-23 1952-01-01 Searle & Co Dihexyl alanine dialkylamides
FR1261160A (fr) * 1955-07-28 1961-05-19 Procédé de préparation de n-t-alkyl-dialkylamino-amides
NL109859C (es) * 1957-09-27
US3185678A (en) * 1961-08-04 1965-05-25 Colgate Palmolive Co Polymethyleniminoalkylamides
US3178439A (en) * 1963-05-06 1965-04-13 Reilly Tar & Chem Corp N-alkanoyl and alkenoyl hydroxy alkyl piperidides
CH448086A (de) * 1965-01-15 1967-12-15 Geigy Ag J R Verfahren zur Herstellung von neuen Derivaten des 1,2,3,6-Tetrahydro-pyridins
DE1719388B2 (de) * 1968-02-09 1976-04-29 Bayer Ag, 5090 Leverkusen Verfahren zum faerben von fasermaterialien aus polyacrylnitril oder acrylnitrilhaltigen mischpolymerisaten
GB1415682A (en) * 1972-06-30 1975-11-26 Wyeth John & Brother Ltd Amides and thioamides
GB1420758A (en) * 1972-07-12 1976-01-14 Wyeth John & Brother Ltd Anti-ulcer compositions
US3968211A (en) * 1974-02-11 1976-07-06 The Upjohn Company Compositions and methods of use of amidines for anti-arrhythmic purposes
JPS5344573A (en) * 1976-10-01 1978-04-21 Teijin Ltd Optical active 2-piperidineethanols and their preparation
US4316903A (en) * 1977-07-18 1982-02-23 Merck & Co., Inc. Anti-microbial piperidino buten-2-ones
JPS55129255A (en) * 1979-03-28 1980-10-06 Kuraray Co Ltd Farnesylacetamide compounds or their salts
DE2947649A1 (de) * 1979-11-27 1981-08-06 C.F. Spiess & Sohn GmbH & Co, 6719 Kleinkarlbach Insektizide mittel
US4565819A (en) * 1979-12-07 1986-01-21 Adir Substituted imino diacids, their preparation and pharmaceutical compositions which contain them
US4326067A (en) * 1980-12-03 1982-04-20 The Dow Chemical Company Process for making N-(2-aminoethyl)amides
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
DE3433036A1 (de) * 1984-09-08 1986-03-20 Basf Ag, 6700 Ludwigshafen Piperidinderivate und diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen
US4812451A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha.
US4906659A (en) * 1985-06-18 1990-03-06 Takeda Chemical Industries, Ltd. Antibiotic tan-749, its derivatives, production and use thereof
CA1318913C (en) * 1986-02-01 1993-06-08 Toshiro Kamishiro Alkylenediamine derivatives
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
DK168069B1 (da) * 1987-11-11 1994-01-31 Hoffmann La Roche Isoquinolinderivater og en fremgangsmaade til fremstilling af octahydroisoquinoliner ud fra derivaterne
FR2649490B1 (fr) * 1989-07-07 1991-09-20 Thomson Csf Capteur de rayonnement d'energie electromagnetique
CA2025490C (en) * 1989-09-22 2003-09-16 James R. Mccarthy Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
DE69016335T2 (de) * 1989-10-06 1995-06-01 Fujirebio Kk Pantothensäure Derivate.
NZ239023A (en) * 1990-07-24 1993-12-23 Merrell Dow Pharma N-substituted-hydroxyalkyl piperidine derivatives and pharmaceutical
CA2047375C (en) * 1990-07-25 2003-04-15 Charlotte L. Barney Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
US5244908A (en) * 1990-07-30 1993-09-14 Takeda Chemical Industries, Ltd. Imidazopyridine derivatives and their pharmaceutical use
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
ZA934777B (en) 1994-01-20
ES2120506T3 (es) 1998-11-01
WO1994001404A1 (en) 1994-01-20
CA2136841A1 (en) 1994-01-20
IL106237A0 (en) 1993-11-15
US5489600A (en) 1996-02-06
EP0650474A1 (en) 1995-05-03
AU4403793A (en) 1994-01-31
DE69320352D1 (de) 1998-09-17
NZ253592A (en) 1996-04-26
KR100286410B1 (ko) 2001-04-16
EP0650474B1 (en) 1998-08-12
CA2136841C (en) 1998-10-06
KR950702534A (ko) 1995-07-29
ATE169618T1 (de) 1998-08-15
AU678973B2 (en) 1997-06-19
JPH07508732A (ja) 1995-09-28
US5350758A (en) 1994-09-27
DE69320352T2 (de) 1998-12-17

Similar Documents

Publication Publication Date Title
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR200000015T2 (tr) Bileşikler ve metodlar
DE69830404D1 (de) P38-inhibitoren
DE69825048D1 (de) Analoga von duocarmycin and cc-1065
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
NO20031159D0 (no) Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
ATE203519T1 (de) Chinolinderivate als antimalariamittel
MX9304070A (es) Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol.
DE69733843D1 (de) Zusammensetzungen und verwendungvon benzamiden als entzuendungshemmende mittel
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DK0506836T3 (da) BCRF1 proteiner som inhibitorer for interferon-gamma
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
BR0014372A (pt) Derivados de 5-hidroxissapogenina com atividade antidemência
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
TR199901385T2 (xx) Piperidin t�revleri.
ATE28188T1 (de) Antikonvulsive mittel.
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
DE69425061D1 (de) Verwendung von einer suspension auf der basis von sucralfatgel als antazidum
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
EA200000946A1 (ru) Кристаллическая форма пароксетина

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees